Disclosed are process steps and novel processes for producing chromane compositions enriched in at least one (2R or 2S) enantiomer, preferably chroman-2-yl carboxylic acid compounds and chroman-2-yl carboxylic acid esters which are intermediates for producing platelet aggregation inhibitors and/or are themselves potent platelet aggregation inhibitors. Further disclosed are enzymatic processes for resolving chiral intermediates or final products to provide desired enantiomers.
揭示了生产富含至少一种(2R或2S)对映体的
香豆素组合物的工艺步骤和新型工艺,优选为
香豆素-2-基
羧酸化合物和
香豆素-2-基
羧酸酯,它们是生产血小板聚集
抑制剂的中间体和/或本身是有效的血小板聚集
抑制剂。进一步揭示了用于解析手性中间体或最终产品以提供所需对映体的酶促过程。